Christine M Cachola, DPM
Podiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cachola’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$23,760
Medicare paid this office $23,760 for 118 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of bone, 20.0 sq cm or less | 14 | $3,994 | $200 |
| Short return visit (20+ min) | 41 | $2,637 | $55 |
| Removal of skin and tissue, 20.0 sq cm or less | 26 | $2,125 | $54 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,064 | $74 |
| Return visit (30+ min) | 21 | $2,037 | $78 |
See all 9 services
| Removal of bone, 20.0 sq cm or less | 14 | $3,994 | $200 |
| Short return visit (20+ min) | 41 | $2,637 | $55 |
| Removal of skin and tissue, 20.0 sq cm or less | 26 | $2,125 | $54 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,064 | $74 |
| Return visit (30+ min) | 21 | $2,037 | $78 |
| Removal of fingernails or toenails, 6 or more nails | 50 | $1,771 | $18 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $782 | $27 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $610 | $16 |
| Removal of noncancer thickened skin growth, 1 growth | 17 | $405 | $12 |
Procedures Medicare counted
| Removal of nail tissue | 175 | More than 73% of doctors who do this |
| Removal of tissue | 84 | More than 84% of doctors who do this |
| Removal or shaving of skin growth | 99 | More than 85% of doctors who do this |
Who their Medicare patients are
118 Original Medicare patients in 2024. Average age 69 · Under 65 23% · Women 38% · Also on Medicaid 86% · Health risk score 3.08. Sicker patients than 9 in 10 peers; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 72% · Chronic kidney disease 45% · Coronary heart disease 36% · Heart failure 36% · Depression 32% · Atrial fibrillation 29% · COPD 14% · Stroke 14% · Dementia 12%.
The office billed $300,489, Medicare allowed $31,185 and paid $23,760; for 433 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 118 | 433 | 69 | 3.08 | $300,489 | $23,760 |
| 2023 | 94 | 298 | 69 | 3.03 | $184,893 | $14,823 |
| 2022 | 147 | 388 | 70 | 2.85 | $219,950 | $18,492 |
| 2021 | 122 | 376 | 67 | 3.23 | $239,873 | $20,725 |
| 2020 | 91 | 381 | 66 | 3.58 | $170,724 | $16,696 |
| 2019 | 302 | 888 | 73 | 2.45 | $314,464 | $31,337 |
| 2018 | 285 | 1,871 | 80 | 1.55 | $135,448 | $73,420 |
| 2017 | 288 | 2,089 | 78 | 1.55 | $140,043 | $78,256 |
| 2016 | 170 | 548 | 79 | 1.50 | $34,360 | $23,857 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 17 | $2,044 | $79 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,814 | $79 |
| Removal of fingernails or toenails, 6 or more nails | 41 | $1,377 | $19 |
| Short return visit (20+ min) | 18 | $1,159 | $55 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $840 | $47 |
| Removal of tissue from wound, 20.0 sq cm or less | 14 | $802 | $31 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $745 | $19 |
2022: 7 services
| Return visit (30+ min) | 29 | $2,909 | $83 |
| Removal of fingernails or toenails, 6 or more nails | 71 | $2,108 | $20 |
| Removal of skin and tissue, 20.0 sq cm or less | 22 | $2,037 | $54 |
| Short return visit (20+ min) | 30 | $1,731 | $48 |
| Removal of noncancer thickened skin growth, 2-4 growths | 25 | $657 | $17 |
| Short return visit | 13 | $501 | $29 |
| Removal of noncancer thickened skin growth, 1 growth | 24 | $383 | $14 |
2021: 8 services
| Short return visit (20+ min) | 50 | $3,042 | $49 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,474 | $113 |
| Removal of tissue from wound, 20.0 sq cm or less | 18 | $1,418 | $31 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $1,338 | $56 |
| Removal of fingernails or toenails, 6 or more nails | 40 | $1,058 | $19 |
| Short return visit | 25 | $900 | $30 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $445 | $17 |
| Removal of noncancer thickened skin growth, 1 growth | 17 | $353 | $14 |
2020: 8 services
| Return visit (30+ min) | 34 | $5,691 | $63 |
| Short return visit (20+ min) | 43 | $2,867 | $46 |
| Removal of tissue from wound, 20.0 sq cm or less | 20 | $1,867 | $32 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $666 | $20 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $527 | $48 |
| Removal of fingernails or toenails, 6 or more nails | 23 | $517 | $18 |
| Removal of noncancer thickened skin growth, 2-4 growths | 18 | $393 | $16 |
| Removal of noncancer thickened skin growth, 1 growth | 11 | $161 | $12 |
2019: 13 services
| Short return visit (20+ min) | 150 | $10,112 | $45 |
| Return visit (30+ min) | 37 | $4,031 | $71 |
| Removal of fingernails or toenails, 6 or more nails | 108 | $3,092 | $21 |
| Removal of tissue from wound, 20.0 sq cm or less | 20 | $1,509 | $21 |
| Removal of noncancer thickened skin growth, 2-4 growths | 37 | $1,104 | $20 |
| Short return visit (20+ min) | 22 | $830 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $716 | $65 |
| Removal of noncancer thickened skin growth, 1 growth | 32 | $560 | $13 |
| Removal of noncancer thickened skin growth, 2-4 growths | 34 | $465 | $13 |
| Removal of fingernails or toenails, 6 or more nails | 44 | $411 | $9 |
| Removal of noncancer thickened skin growth, 1 growth | 14 | $285 | $19 |
| Removal of fingernails or toenails, 1-5 nails | 26 | $235 | $9 |
| Trimming of fingernails or toenails | 16 | $61 | $4 |
2018: 9 services
| Removal of fingernails or toenails, 6 or more nails | 156 | $17,084 | $33 |
| Removal of noncancer thickened skin growth, 2-4 growths | 89 | $15,987 | $43 |
| Short return visit (20+ min) | 82 | $13,292 | $55 |
| New patient visit (30+ min) | 83 | $6,435 | $78 |
| Removal of noncancer thickened skin growth, 1 growth | 35 | $5,016 | $37 |
| Removal of fingernails or toenails, 1-5 nails | 78 | $4,795 | $25 |
| Trimming of fingernails or toenails | 54 | $1,432 | $9 |
| X-ray of foot, minimum of 3 views | 22 | $1,185 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $43 | None |
2017: 10 services
| Removal of noncancer thickened skin growth, 2-4 growths | 111 | $18,885 | $42 |
| Removal of fingernails or toenails, 6 or more nails | 170 | $17,267 | $32 |
| Short return visit (20+ min) | 98 | $13,150 | $54 |
| New patient visit (30+ min) | 94 | $6,247 | $66 |
| Removal of tissue from wound, 20.0 sq cm or less | 16 | $4,676 | $62 |
| Removal of noncancer thickened skin growth, 1 growth | 38 | $4,333 | $37 |
| Removal of fingernails or toenails, 1-5 nails | 68 | $3,581 | $22 |
| X-ray of foot, minimum of 3 views | 32 | $1,218 | $22 |
| Trimming of fingernails or toenails | 50 | $794 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $155 | None |
2016: 8 services
| Removal of fingernails or toenails, 6 or more nails | 96 | $5,289 | $37 |
| New patient visit (30+ min) | 57 | $4,950 | $87 |
| Removal of noncancer thickened skin growth, 2-4 growths | 54 | $4,481 | $49 |
| Short return visit (20+ min) | 32 | $3,149 | $58 |
| Removal of noncancer thickened skin growth, 1 growth | 26 | $1,424 | $40 |
| Removal of fingernails or toenails, 1-5 nails | 22 | $762 | $26 |
| X-ray of foot, minimum of 3 views | 16 | $603 | $24 |
| Trimming of fingernails or toenails | 31 | $321 | $9 |
Medicaid work
$16,603 in 2024
Medicaid paid $16,603 for 2,792 billed services this clinician did in 2024, up to 96 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 136 | $4,013 |
| Short return visit (20+ min) | 276 | $2,711 |
| Service | 37 | $2,318 |
| Debridement, bone (includes epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed); first 20 sq cm or less | 16 | $1,519 |
| Return visit (30+ min) | 98 | $1,122 |
| Service | 503 | $1,097 |
| New patient visit (30+ min) | 72 | $1,042 |
| Debridement of nail(s) by any method(s); 6 or more | 414 | $961 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 109 | $781 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 87 | $444 |
| Short return visit | 73 | $437 |
| Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less | 32 | $158 |
| 2024 | 2,792 | 19 | 96 | $16,603 |
| 2023 | 1,526 | 12 | 40 | $6,390 |
| 2022 | 967 | 7 | 38 | $3,743 |
| 2021 | 629 | 4 | 37 | $2,698 |
| 2020 | 660 | 4 | 51 | $1,898 |
| 2019 | 1,221 | 7 | 69 | $4,734 |
| 2018 | 1,170 | 4 | 71 | $3,771 |
See the largest Medicaid services in earlier years
2023
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 126 | $1,743 |
| Short return visit (20+ min) | 312 | $1,294 |
| Debridement of nail(s) by any method(s); 6 or more | 265 | $935 |
| Return visit (30+ min) | 191 | $762 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 122 | $579 |
| New patient visit (30+ min) | 57 | $391 |
| Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less | 17 | $205 |
| Service | 321 | $187 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 38 | $177 |
| Short return visit | 27 | $118 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 31 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 19 | $0 |
2022
| Short return visit (20+ min) | 343 | $1,204 |
| Return visit (30+ min) | 183 | $874 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 67 | $722 |
| Debridement of nail(s) by any method(s); 6 or more | 270 | $705 |
| Short return visit | 58 | $160 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 32 | $77 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 14 | $0 |
2021
| Short return visit (20+ min) | 300 | $1,459 |
| Short return visit | 232 | $970 |
| Debridement of nail(s) by any method(s); 6 or more | 85 | $195 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 12 | $75 |
2020
| Short return visit (20+ min) | 271 | $1,000 |
| Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less | 81 | $486 |
| Debridement of nail(s) by any method(s); 6 or more | 74 | $336 |
| Return visit (30+ min) | 234 | $76 |
2019
| Debridement of nail(s) by any method(s); 6 or more | 243 | $1,692 |
| Short return visit (20+ min) | 533 | $1,431 |
| Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound assessment, use of a whirlpool, when performed and instruction(s) for ongoing care, per session, total wound(s) surface area; first 20 sq cm or less | 146 | $932 |
| Return visit (30+ min) | 195 | $386 |
| New patient visit (30+ min) | 47 | $256 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 42 | $21 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 15 | $17 |
2018
| Debridement of nail(s) by any method(s); 6 or more | 383 | $2,288 |
| Short return visit (20+ min) | 651 | $1,369 |
| New patient visit (30+ min) | 110 | $113 |
| Clinic visit/encounter, all-inclusive | 26 | $0 |
Drugs they prescribed that Part D paid
$2,905
Pharmacies billed $2,905 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
131 generic and 0 brand-name prescriptions · $2,905 in drug cost · 19 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clotrimazole | 64 | $1,755 | $27 |
| Lidocaine | 15 | $243 | $16 |
| Amoxicillin-Clavulanate Potass | 12 | $134 | $11 |
Year by year
| 2024 | 131 | 45 | None | 0% | $2,905 |
| 2023 | 75 | 32 | None | 0% | $2,438 |
| 2022 | 56 | 28 | None | None | $2,902 |
| 2021 | 62 | 29 | None | None | $1,900 |
| 2020 | 53 | 27 | 0% (0) | None | $1,370 |
| 2019 | 179 | 72 | None | None | $5,724 |
| 2018 | 368 | 166 | None | 9% | $18,338 |
| 2017 | 248 | 116 | None | 5% | $7,678 |
| 2016 | 59 | 37 | 0% (0) | None | $2,121 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Clotrimazole | 33 | $1,012 | $31 |
| Ammonium Lactate | 14 | $350 | $25 |
2022: 1 drug
| Clotrimazole | 18 | $507 | $28 |
2021: 1 drug
| Clotrimazole | 25 | $779 | $31 |
2020: 1 drug
| Clotrimazole | 22 | $676 | $31 |
2019: 3 drugs
| Clotrimazole | 75 | $3,179 | $42 |
| Ciclopirox | 38 | $1,174 | $31 |
| Lidocaine-Prilocaine | 14 | $292 | $21 |
2018: 6 drugs
| Clotrimazole | 157 | $6,227 | $40 |
| Ciclopirox | 41 | $1,348 | $33 |
| Clotrimazole-Betamethasone | 43 | $1,205 | $28 |
| Diclofenac | 27 | $914 | $34 |
| Lidocaine-Prilocaine | 18 | $441 | $25 |
| Cephalexin | 21 | $191 | $9 |
2017: 4 drugs
| Clotrimazole | 124 | $4,638 | $37 |
| Clotrimazole-Betamethasone | 33 | $630 | $19 |
| Cephalexin | 30 | $295 | $10 |
| Hydrocortisone | 13 | $66 | $5 |
2016: 2 drugs
| Clotrimazole | 27 | $1,119 | $41 |
| Cephalexin | 14 | $135 | $10 |
Money from drug and device companies
$23 in 2022
A payment is not proof that care is biased.
| Smith+Nephew | Stravix | $23 | 1 payment
|
See the published payment
| Smith+Nephew | Meals · 2022-12-22 | Stravix | $23 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1104286988
- Licence
- CA E5252
- Trained
- California School of Podiatric Medicine, 2013
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 16 E Fern Ave, Redlands, CA, 92373
- NPI first listed
- 2016-03-07
- NPI last updated
- 2016-03-07
This is when the NPI record was last certified, not a medical board exam.